Final combined fill volume [pending] · Pack imagery represents current concept and is subject to change.
AUREVIA CD//CORE
The foundation of the AUREVIA cyclodextrin platform.
AUREVIA CD//CORE is the cleanest and most focused formula in the AUREVIA CD collection. A dedicated aqueous phase carries α-cyclodextrin and HPβCD, paired with a separately stored cholesterol-free phospholipid phase. The two phases remain separated during storage and combine immediately before use — an architecture intended to reduce prolonged pre-use interaction between the cyclodextrins and the liposomal phospholipids.
Not available for purchase until finished-product validation is complete.
Cyclodextrin intelligence. Liposomal precision.
Each daily unit contains two connected chambers — a purified aqueous cyclodextrin matrix and a separately manufactured phospholipid phase — combined only at the moment of use.
Phase One — Cyclodextrin Matrix
- α-CyclodextrinFinal quantity pending regulatory approval
- Principal gut-phase cyclodextrin component
- Soluble-fibre-style formulation ingredient
- Supports the digestive lipid-pathway positioning
- Mechanistically distinct role from HPβCD
Human evidence for α-CD is mixed. Not presented as a guaranteed cholesterol-lowering ingredient.
- HPβCD (2-Hydroxypropyl-β-cyclodextrin)Pending regulatory, toxicological and safety review
- Advanced cyclodextrin-research component
- Supports cholesterol inclusion and exchange research
- Creates a differentiated technical platform
Preclinical mouse findings must not be presented as proof of oral plaque removal in humans.
- Purified water
- Primary aqueous carrier
- Vegetable glycerin
- Liquid-gel texture
- Mouthfeel
- Viscosity control
- Palatability support
- Buffering system
- pH control
- Ingredient stability
- Taste management
- Packaging compatibility
- Natural flavour system
- Restrained citrus or neutral flavour, pending sensory evaluation
Phase Two — Liposomal Support Matrix
- Sunflower phosphatidylcholine
- Cholesterol-free phospholipid source
- Liposomal / phospholipid-vesicle formation
- Carrier for lipid-compatible components
- Separation from the cyclodextrin chamber during storage
- Natural mixed tocopherols
- Oxidative protection of the phospholipid phase
- Shelf-life support
- Stability of lipid-sensitive components
Not promoted as a principal cardiovascular active unless separately substantiated.
Designed to support.
Proposed structure/function positioning. Requires final formulation-specific substantiation and regional regulatory approval.
- Healthy lipid-metabolism pathways
- Digestive lipid handling
- General cardiovascular wellness
- A structured heart-health routine
- Consumer access to a differentiated cyclodextrin formulation platform
Combines α-CD and HPβCD as two technically distinct cyclodextrin components.
The cyclodextrin and phospholipid phases remain separated until use.
Sunflower-derived phosphatidylcholine — no cholesterol added to the liposomal matrix.
Designed to support separate chamber testing and finished-product characterisation.
Nothing hidden.
Final quantities are declared once formulation and regulatory review are complete.
| Ingredient | Role | Per serving | Evidence |
|---|---|---|---|
| α-Cyclodextrin | Gut-phase cyclodextrin | TBC | Emerging |
| HPβCD | Advanced cyclodextrin research | TBC | Mechanistic |
| Sunflower phosphatidylcholine | Cholesterol-free liposomal carrier | TBC | Established |
| Mixed tocopherols | Lipid-phase antioxidant | TBC | Established |
| Vegetable glycerin | Texture & palatability | TBC | Established |
The foundational AUREVIA DualPhase™ formula.
Rather than storing cyclodextrins and phospholipids together for the entire shelf life, CD//CORE keeps them in two dedicated chambers until use.
Avoids the large number of co-active ingredients used in more advanced products — the preferred formula for analytical validation, cyclodextrin-fraction testing and simulated digestion.
Not positioned as an artery-clearing treatment. A carefully designed dual-phase cyclodextrin and phospholipid system for adults building a modern cardiovascular-wellness routine.
- Adults interested in general cardiovascular wellness
- Consumers focused on healthy lipid-metabolism pathways
- Existing cyclodextrin users seeking a differentiated oral format
- Early adopters interested in formulation technology
- Practitioners assessing new supplement-delivery platforms
- Consumers seeking a simpler introduction to the AUREVIA CD collection
Consult a qualified healthcare professional before use if you:
- Are pregnant or breastfeeding
- Take prescription medication
- Have kidney or liver disease
- Have diagnosed cardiovascular disease
- Use lipid-lowering medication
- Are receiving specialist medical care
- Are preparing for surgery or another medical procedure
- Have experienced sensitivity to cyclodextrins or formulation ingredients
Do not discontinue or replace prescribed treatment.
Questions we get, answered honestly.
Does the phospholipid phase completely fill the HPβCD cavities?+
That should not be assumed. Cyclodextrin inclusion is dynamic and dependent on the complete formulation environment. CD//CORE is designed to reduce prolonged pre-use interaction by storing the phases separately. Actual free, exchangeable and complexed fractions must be measured in the finished product.
Does CD//CORE remove arterial plaque?+
No such claim is made. The finished product has not been shown to remove plaque, reverse atherosclerosis or replace medical treatment.
Why include both α-CD and HPβCD?+
They serve different proposed formulation purposes. α-CD is positioned primarily around the digestive lipid pathway; HPβCD provides the more advanced cholesterol-interaction research platform.
Is the finished product clinically tested?+
Not yet. Ingredient research cannot be treated as finished-product clinical evidence.
The rest of the DualPhase™ collection.
Advanced cardiovascular longevity formula. Multi-pathway wellness across two precisely separated phases.
Practitioner circulation system supporting endothelial wellness, nitric-oxide pathways and fibrinolytic balance.